Tucson, AZ, United States of America

Uffe Lovborg


 


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 43(Granted Patents)


Location History:

  • Carpinteria, CA (US) (2011)
  • Santa Barbara, CA (US) (2014)
  • Tucson, AZ (US) (2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Uffe Lovborg: Innovator in Prostate Cancer Detection

Introduction

Uffe Lovborg is a notable inventor based in Tucson, AZ (US), recognized for his contributions to the field of prostate cancer detection. With a total of 3 patents, Lovborg has made significant strides in developing innovative methods and compositions that enhance the detection of prostate cancer.

Latest Patents

One of Lovborg's latest patents focuses on a prostate cancer biomarker. This invention relates to villin as a novel prostate biomarker, along with compositions that comprise anti-villin antibodies. These compositions are designed for improved detection of prostate cancer in subjects. Another significant patent involves methods and compositions for immuno-histochemical detection. This invention outlines a process for detecting a biological marker in a sample, utilizing a series of binding agents and detectable substances to enhance the accuracy of detection.

Career Highlights

Uffe Lovborg is associated with Dako Denmark A/S, a company known for its advancements in diagnostic solutions. His work has contributed to the development of innovative technologies that aid in the early detection of prostate cancer, ultimately improving patient outcomes.

Collaborations

Lovborg has collaborated with notable colleagues, including Marc E Key and Scott A Devore, to further advance research and development in the field of cancer detection.

Conclusion

Uffe Lovborg's innovative work in prostate cancer detection exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in diagnostic technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…